Skip to content
healthcare.dev

Clindamycin phosphate

NDC 43066-993, Clindamycin phosphate, injection, solution, from Baxter Healthcare Corporation.

Product NDC
43066-993
Status
Listed
Labeler
Baxter Healthcare Corporation
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208084
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/43066-993 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CLINDAMYCIN PHOSPHATE600 mg/50mL

Pharmacologic classes

Decreased Sebaceous Gland Activity [PE]; Lincosamide Antibacterial [EPC]; Lincosamides [CS]; Neuromuscular Blockade [PE]

Package NDCNDC-11Package
43066-993-244306609932424 BAG in 1 CASE (43066-993-24) / 50 mL in 1 BAG

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1a42c3b2-90b5-4a78-9f18-fa789742b033
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=43066-993

Use it

Look up 43066-993 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/43066-993 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 43066-993. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.